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Abstract:  
 
Background/ Objective: The main health status indicators in the SAARC-ASEAN region are far behind 
than those of OECD group and world average. Similarly, total health expenditure (% of GDP) in the region 
is also lower than that of OECD region and world. Therefore, this study aims to investigate a relationship 
between the healthcare expenditures and three main health status outcomes (life expectancy at birth, crude 
death rate and infant mortality rate) in the region. 
Methods: Using the World Bank data set for 20 years (1995-2014) in 15 countries of the region, a panel 
data analysis is conducted where relevant fixed and random effect models are estimated to determine the 
effects of healthcare expenditures on health outcomes. The separate effects of private and public health 
expenditures were also explored. 
Results: Total health expenditure, public health expenditure and private health expenditure have significant 
effect in reducing infant mortality rate and the extent of effect of private health expenditure is greater than 
that of public health expenditure. Private health expenditure also has significant role in reducing crude 
death rate. However, the study has not found any significant effect of health expenditure on life expectancy 
at birth. Per capita income growth and improved sanitation facilities have also significant positive roles in 
improving population health in the region. 
Conclusion: Healthcare expenditures, along with income growth rate and improved sanitation facilities, 
should be considered as an important determinant in improving population heath status in the region. The 
government and private joint initiatives should continue side by side to take the right actions for improving 
the health status outcomes. 
Keywords: Healthcare expenditures; health status outcomes; panel data; SAARC; ASEAN. 
JEL Codes: I10; I15; I18; C23. 
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1. Introduction 
 
Enriched human capital is considered as one of the important factors for achieving desired economic growth 
and development (Novignon, et al 2012; Romer, 1996) in any country. According to the neoclassical growth 
model, growth in human capital, in terms of education and health, positively affects per capita income in 
the long run (Romer, 1996). Bloom and Canning (2000 and 2003) and Bloom et al (2004) identified four 
mechanisms through which healthier individuals contribute to the economy: (i) at the workplace, healthier 
individuals are more productive and thus generally earn higher income; (ii) their working time in the 
workforce is longer and hence retire late, and take fewer sick leave; (iii) they are likely to invest more in 
their own education and training that enhance the productivity; and (iv) they are likely to save and invest 
more with the expectation of longer life. So health is the integral part of sustainable development, and 
attempts for its improvement and expansion should always be the main development goal for a nation 
(WHO 2000). Furthermore, good health provides a kind of empowerment that adds value to human life 
(Sen 1999), and it also ensures economic security for the individuals and families (Karim 2016).  
 
Therefore, it is vital for all countries to invest in the health sector properly. Evidence show that investing 
in health brings a lot of benefits for the economy (Anyanwu and Erhijakpor 2007; Bloom et al 2004). For 
example, a WHO report (Commission on Macroeconomics and Health, 2001) reveals that economic growth 
rate will increase by 0.35% per year with the increasing life expectancy at birth by 10%. Similarly, ill health 
is considered as a huge financial burden, and it is the major cause of 50% of the growth differential between 
developed and developing countries. Despite the importance of health investment, health expenditure in 
government budgets in developing regions like South Asian Association for Regional Cooperation 
(SAARC) and Association for South East Asian Nations (ASEAN) could not attract adequate attention due 
to the scarcity of resources (WHO 2010).  
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Realizing the importance of population health and its contribution to national economy, researchers have 
been conducting studies to explore the link between healthcare expenditures and health sector outcomes for 
more than two decades. However, the most of these studies are based on the developed countries (see, for 
example, Anderson and Poullier, 1999; Babazono and Hillman 1994; Beger and Messer, 2002; Cochrane 
et al, 1978; Crémieux et al 1999; Crémieux et al 2005; Elola et al. 1995; Hitiris and Possnett,1992; Or, 
2000; Nixon and Uimann, 2006; Wolfe and Gabay, 1987) but such studies on developing countries/region 
are limited. To the best of our knowledge, no such study that uses macro data, has yet been conducted in 
SAARC-ASEAN region.  Moreover, the health sector and health expenditures have been changed a lot 
during the last decade. So a recent study is warranted. This is our main motivation for conducting current 
research on a panel of 15 countries that will fill up the gap in the literature. Furthermore, the debate on the 
relationship between health care expenditures and health outcomes are still inconclusive (Novignon et at 
2012). This study will help mitigate this debate by providing new evidence from a new region. Our 
additional contributions are that we have addressed the endogeneity issue of the concerned variables, and 
looked for the effects of healthcare expenditures on three health status indicators while most of the studies 
investigate the effect only on one or two indicators. 
 
Therefore, the main purpose of this study are: (i) to explore the impact of total health care expenditure on 
three health outcomes - life expectancy at birth, crude death rate and infant mortality rate in SAARC-
ASEAN region, and (ii) to find out the differentiated influences of public and private health care 
expenditures on these health outcomes. We have also explored the impact of two controlled variables- real 
GDP per capita and improved sanitation facilities.  
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The rest of the paper is structured as follows: section 2 outlines the past empirical literature, section 3 briefly 
highlights the regional profiles, section 4 describes model, data and methodology; section 5 presents and 
analyses empirical results, and section 6 concludes the paper with policy implications. 
 
2. Past literature  
The past empirical studies on the relationship between healthcare expenditures and health sector outcomes 
provide conflicting views. For example, the studies of Anand and Ravallion (1993), Patricio (2008) and 
Imoughele et al (2013) revealed a positive relationship between public healthcare expenditure and health 
sector performance for Sri Lanka, Russia and Nigeria, respectively. On the other hand, Filmer and Pritchett 
(1997), Musgrove (1996) and Kim and Moody (1992) found no relationship on these variables. Filmer and 
Pritchett (1997) identified that rather than the public health expenditure, the level of poverty, income 
inequality, female education, and other socio-economic factors are the main determining factors of child 
mortality. Further, a World Bank study on Indian states during 1980-99 used panel data, and found no 
effects of healthcare expenditure on infant mortality rates (World Bank 2004), which are similar to the 
findings of Burnside and Dollar (1998). Some other studies like Zakir and Wunnava (1999), Nolte and 
Mckec (2004) and Young (2001) also found no significant and consistent relationship between health 
spending and health outcomes. 
 
In a separate study in Brazil, Alves and Belluzzo (2005) employed static panel data models to explore the 
determinants of infant mortality rates where they used census data for the period of 1970-2000. They found 
that the levels of education, sanitation and poverty are the main factors of infant mortality rates. The same 
experience is also noted by the studies of Meara (2001), Currie and Moretti (2003) and Filmer (2003). 
 
In relation to the positive effects of healthcare expenditures on health outcomes, more empirical evidences 
are found worldwide. In a study on 47 African countries between 1999 and 2004, Anyanwu and Erhijakpor 
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(2007) found that total healthcare expenditure significantly affect health outcomes as expected: a 1% 
increase of total health care expenditure per capita decreases 2.1% and 2.2% under five and infant mortality 
rates, respectively. Similarly, Akinkugbe and Mohanoe (2009) also found significant effect of healthcare 
expenditure, along with other variables, on health outcomes. From the cross-country data on the relationship 
between public health expenditure and health status, Gupta et al (2001) further found significant and 
stronger effects for the poor people. In another study on 50 developing and transition countries, Gupta et al 
(1999) revealed that health expenditures reduced child mortality rates in 1994.  Similarly, Issa and Ouattara 
(2005) found a strong negative relationship between health spending and infant mortality rates in a panel 
study of 160 countries where they separated the health expenditure into public and private. The same results 
on infant and child mortality rates are also observed by the studies of Paxson and Scady (2005) and Wang 
(2002) in relation to private health expenditure and public health expenditure, respectively. Significant 
negative effects of health care expenditure on mortality rate were also revealed by Berger and Messer 
(2002) for 20 OECD countries over the period of 1960-1992, Gani (2009) for Pacific Island countries over 
the period of 1990-2002 and Farag (2010) for Eastern Mediterranean region during the 1995-2006 period. 
 
 
3. Brief profile of SAARC-ASEAN region 
 
SAARC or South Asian population are 1744 million which is 23.75% of the world population. ASEAN 
Population are 625 million which is 8.8% of the world population. Together SAARC-ASEAN region 
comprises 32.55% of the world population, and 5.81% of the world GDP (WDI 2016). Hence the region 
has significant position in the world, and therefore the current study on the region is critical. Moreover, the 
economic, political and social structures of the countries in the region are more or less similar. 
 
 
6 
 
Table 1 highlights the trend of health care expenditures of South Asia (SAARC countries) and South East 
Asia (ASEAN countries) against the OECD group and the world for selected years. It is observed that 
though total health expenditure (% of GDP) has an increasing trend over the years in SAARC-ASEAN 
regions it is far below than the health expenditure in the OECD region and world. In 2014, while share of 
total health expenditure was 12.36% of GDP in OECD countries and 9.97% in the word, it is only 4.37% 
in South Asia and 4.72% in South East Asia. Between 2005 and 2014, the growth rate of total health 
expenditure in OECD countries was 12.5%, but this growth rate is only 7% in South Asia and 11% in South 
East Asia. 
The condition of public health expenditure (% of government expenditure) is very poor is South Asia. All 
along it is less than one third of the OECD countries, and more or less half of the South East Asian countries. 
Even it is one third of the world average. Although the share of South East Asia is better than that of South 
Asia, it is still half of the OECD and World average. The growth rate of public health expenditure over the 
years is not convincing at all for South Asia (increased to 5.25% only in 2014 from 4.80% in 2005) against 
the increase of South East Asia (increased to 10.42% in 2014 from 8.18% in 2005) and the OECD countries 
(increased to 17.76% in 2014 from 16.23% in 2005). Poverty in the region especially in South Asia may be 
the main reason for this low public health expenditure which is a major concern for expected heath status 
outcomes. 
Out of pocket health expenditure (% of private expenditure on health) in both South Asia and South East 
Asia has decreased slightly over the years along the line of OECD countries; however this is still too high 
in SAARC and ASEAN regions compared to the OECD and world average. For South Asia, out of pocket 
health expenditure is double of world average, and for South East Asia, it is almost double. While this 
share is just 36.01% in OECD group in 2014, it is 89.41% for South Asia and 80.07% for South East 
Asia. This high proportion of out-of-pocket health spending is a great concern which will aggravate 
existing poverty and welfare of the vast population. 
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Table1: Trend in health care expenditure for selected regions (selected years) 
Regions Total health 
expenditure (% of 
GDP) 
Public health expenditure 
(% of government 
expenditure)  
Out of pocket health 
expenditure (% of private 
expenditure on health) 
 1995 2005 2014 1995 2005 2014 1995 2005 2014 
South 
Asia 
3.76 4.07 4.37 4.43 4.80 5.25 92.17 89.36 89.41 
South 
East 
Asia 
3.69 4.24 4.72 7.64 8.18 10.42 86.41 84.60 80.07 
OECD 
group 
9.23 10.99 12.36 13.41 16.23 17.76 41.42 37.58 36.01 
World 8.52 9.80 9.97 -- 15.39* 15.61** 45.90 43.33 45.80 
Note: * data for 2010; ** data for 2011. 
Source: World Development Indicators, World Bank (2016). 
 
Table 2 provides the trend of health status outcomes of the SAARC and ASEAN regions in comparison 
with the OECD group and world. It is observed that though total life expectancy at birth (years) has 
increasing trend over the years in SAARC-ASEAN region, it is always lower than that of OECD group. 
Especially total life expectancy in South Asia is always lower than that of the world average, indicating 
the poor health status in the region. While world average is 71.45 years in 2014, it is just 68.12 years in 
South Asia. 
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Infant mortality rate per 1000 live birth has improved tremendously in SAARC-ASEAN region over the 
years. It has decreased from 80.10 in 1995 to 43.30 in 2014 in South Asia. In South East Asia, it has 
decreased to 20.26 in 2014 from 42.44 in 1995. However, it (especially for South Asia) is still much 
higher than the OECD average (6.09) and the world average (32.60) in 2014, implying again the poor 
health status in the study region. 
 
Crude death rate per 1000 people in the region has the similar trend like the OECD group and the world. 
Over the years it has been declining slightly. In 2014, it was 7.16 for the South Asia, 6.27 for the South 
East Asia, 8.10 for the OECD group and 7.75 for the world. 
 
Table 2: Health status outcomes for selected regions (selected years) 
Health 
outcome 
South Asia South East Asia OECD group World 
 1995 2005 2014 1995 2005 2014 1995 2005 2014 1995 2005 2014 
Total life 
expectanc
y at birth 
(years) 
60.6
8 
60.8
0 
68.1
2 
66.5
7 
69.8
8 
72.3
6 
75.7
0 
78.2
5 
80.1
3 
66.2
8 
69.0
1 
71.4
5 
Infant 
mortality 
rate per 
80.1
0 
58.3
0 
43.3
0 
42.4
4 
28.9
4 
20.2
6 
13.5
0 
8.57 6.09 60.0
0 
44.3
0 
32.6
0 
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1000 live 
birth 
Crude 
death rate 
per 1000 
people 
9.49 7.93 7.16 7.29 6.35 6.27 8.51 8.07 8.10 8.95 8.25 7.75 
Source: Word Development Indicators, World Bank (2016). 
 
 
4.0 Methodology, Model and Data  
 
In the literature different estimation methods (e.g. cross sectional analysis, panel, autoregressive 
distributed lag model, etc.) have been used to analyse the relationship between healthcare expenditures 
and health status outcomes. For a study that covers a number of countries, a panel estimation is the best 
approach to follow. Panel data analysis has always an advantage over the cross sectional analysis. 
Therefore, our chosen method for this research is a panel data analysis. 
 
Following Novignon et al. (2012), we adopt a health outcome model as follow: 
𝑦𝑖𝑡 =  𝐻𝑖𝑡𝛽 + 𝜀𝑡, 𝑡 = 1 … . . 𝑇………………….…………………..…………………(1) 
εt = μZ + ѵ ……………………………………...……………………………………(2) 
 
Where 𝑦𝑖𝑡  is a vector of dependent variables in country i at time t, H is a vector of exogenous variables, 
including the constant, and β is a vector of coefficients. 𝜀𝑡 is a vector of random error terms. Baltagi et al. 
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(2007) propose two components of the error process such as time variant and reminder error process. The 
error term is spatial weights matrix, Z, and contains spatial autocorrelation parameter μ. 
 
We have also considered the effects of two controlled variables: real per capita income and improved 
sanitation facilities. These two variables are chosen following the earlier literature and based on the 
availability of data in the countries of study.  Therefore, to investigate the effects of health care expenditure, 
real per capita income and sanitation on health outcomes in this study, we specify the following equation: 
 
HSit  = α + β1THEit + β2GDPit + β3SANit + εit ………………………………..……….. (3) 
 
 
Where,   HS denotes three health outcomes variables, namely total life expectancy at birth (years), infant 
mortality rate (per 1,000 live births) and crude death rate (per 1,000 people). THE is total health expenditure 
(% of GDP), and GDP represents for per capita gross domestic product (constant 2005 US$) and SAN is 
the improved sanitation facilities.  
 
Total health expenditure is the summation of two types of health expenditure: Public and private health 
expenditures. Public health expenditure includes social security contributions, taxation to private and public 
sectors and foreign resources like loans and grants. On the other hand, private health expenditure includes 
private health insurance premium, direct payments or out- of – pocket health expenditure, etc. (Novignon 
2012; Lu et al 2010). Both private and public health expenditures have different effects on the health status. 
For example, an increase of out-of- pocket health expenditure, one of the private health expenditures,   
reduces the people’s spending ability on other goods and services, which may lead to more poverty. On the 
other hand, an increase of public health expenditure may lead to increase of the government budget deficit, 
but it will decrease the burden of people’s private health expenditure. Increased public health expenditure 
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contributes to improve society’s health, implying improved human capital that eventually leads to higher 
economic growth in an economy (Yardim, et al 2010). Thus we analyse the individual impact of these two 
components on health outcomes using the following equation: 
 
HSit  = α + β1PUBit + β2PRIit + β3GDPit + β4SANit +  εit………………………….…….. (4) 
 
 
 
Where, PUB and PRI represent public health care expenditure and private health care expenditure, 
respectively. All variables are in natural logarithm. The subscripts i and t represent country and time, 
respectively. 
Firstly, we run fixed effect model GLS and random effect model GLS (with cross-section weights). Baltagi 
et al. (2007) argue that the random effect model will be more suitable when error term is considered not 
serially correlated with the reminder error and there is no spatial serial dependence of error terms. Cameron 
and Trivedi (2005) argue that fixed effect may be used to control endogeneity in panel data where 
endogeneity arises owing to a time-invariant omitted variables.  We conduct the Hausman Test to find out 
whether the fixed effect or random effects model is the most appropriate model. In addition, we address the 
potential endogeneity issue by adopting the Panel Generalized Method of Moments (GMM). Arellano and 
Bond (1991) propose that the use of instrumental variable GMM mitigates the endogeneity problem with 
explanatory variables.  Also GMM is very useful to estimate extensions of the basic unobserved effects 
model (Wooldridge 2002). 
 
Initially, we collect annual data from 1960 to 2014 (55 years) from the World Development Indicators 
(WDI), World Bank database for 17 countries of two regions of South Asia (SAARC) and South East Asia 
(ASEAN), namely Bangladesh, Bhutan, Brunei Darussalam, Cambodia, India, Indonesia, Lao PDR, 
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Malaysia, Maldives, Myanmar, Nepal, Pakistan, Philippines, Singapore, Sri Lanka, Thailand and Vietnam. 
The chosen variables for collected data are total life expectancy at birth (years), infant mortality rate (per 
1,000 live births), crude death rate (per 1,000 people), per capita real GDP, improved sanitation facilities 
(% of population with access), total health expenditure (% of GDP), public health expenditure (% of 
government expenditure) and private health expenditure, i.e. out-of-pocket health expenditure (% of private 
expenditure on health). Due to lack of data for all countries and for all years, we have to limit the study to 
15 countries excluding Myanmar and Brunei Darussalam for the period of 1995 - 2014 (20 years). 
 
5. Empirical results and analysis 
 
Table 3 provides the mean and standard deviation of life expectancy at birth (LIF), mortality rate (MOR) 
and death rate (DEA),  per capita real GDP (GDP), total health expenditure (THE), public health 
expenditure (PUP), private health expenditure (PRI) and improved sanitation facilities (SAN). The highest 
and the lowest mean of LIF of 79.54 and 61.32 are reported in Singapore and Lao PDR, respectively.  The 
highest and lowest mean death rates are 8.77 and 4.33 for Lao PDR and Maldives, respectively. The lowest 
mean value of mortality (2.73) and the highest mean values of GDP and SAN (1319.45 and 99.84, 
respectively) are reported in Singapore. While, the lowest mean of total health expenditure is reported for 
Indonesia (2.50), it is the highest for Maldives. The highest and the lowest means of public health 
expenditure are for Thailand (16.72) and India (4.39). The highest mean of private health expenditure is for 
Bhutan (98.07), and the lowest mean of it for Maldives (65.26).  For Cambodia, the sanitation facilities are 
minimum among the sample countries. 
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Table 3: Descriptive statistics of variables 
  LIF DEA MOR GDP THE PRI PUB SAN 
Bangladesh 
Mean 67.37 6.43 53.57 509.00 2.73 94.83 7.87 50.06 
Std. Dev. 2.98 0.89 15.29 121.80 0.30 2.25 0.96 6.13 
Bhutan 
Mean 63.85 7.79 48.37 1343.95 5.59 98.07 12.26 37.89 
Std. Dev. 4.26 1.55 14.93 420.86 1.30 2.25 3.26 8.86 
Cambodia 
Mean 62.06 8.14 58.36 468.01 5.83 94.30 9.73 24.13 
Std. Dev. 4.44 1.75 22.47 161.03 0.83 8.62 3.82 10.27 
India 
Mean 64.33 8.25 57.46 768.06 4.29 89.99 4.39 30.10 
Std. Dev. 2.33 0.68 11.99 244.75 0.18 1.69 0.30 5.85 
Indonesia 
Mean 67.06 7.24 35.30 1336.29 2.50 74.82 5.00 51.38 
Std. Dev. 1.17 0.06 8.47 259.47 0.39 1.56 0.75 6.03 
Lao PDR 
Mean 61.32 8.77 72.63 504.03 3.63 78.71 6.11 42.55 
Std. Dev. 3.18 1.53 14.30 158.28 1.03 10.62 2.15 16.96 
Malaysia 
Mean 73.43 4.58 7.95 5587.07 3.51 76.59 5.60 92.96 
Std. Dev. 0.85 0.17 1.69 929.23 0.45 1.98 0.58 2.40 
Maldives 
Mean 72.74 4.31 25.03 4223.96 7.86 65.26 15.49 86.86 
Std. Dev. 3.78 0.88 15.09 703.87 2.05 15.06 4.04 9.74 
Nepal 
Mean 64.76 7.80 49.76 325.83 5.85 84.81 11.19 28.93 
Std. Dev. 3.47 1.25 14.50 52.21 0.44 7.35 2.52 9.66 
Pakistan 
Mean 63.82 8.34 81.43 693.06 2.83 87.07 4.13 44.90 
Std. Dev. 1.44 0.67 8.96 78.54 0.27 5.65 0.51 10.59 
Philippines 
Mean 67.18 6.28 27.77 1230.63 3.76 81.75 8.12 66.80 
Std. Dev. 0.67 0.20 3.17 206.24 0.58 2.78 0.88 3.94 
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Singapore 
Mean 79.54 4.48 2.73 29060.14 3.49 94.70 9.04 99.84 
Std. Dev. 2.03 0.24 0.67 5641.49 0.69 1.17 2.13 0.21 
Sri Lanka 
Mean 72.73 6.69 12.39 1319.45 3.66 84.04 7.30 85.87 
Std. Dev. 2.02 0.46 2.88 374.54 0.29 4.59 1.62 6.14 
Thailand 
Mean 72.10 7.09 16.24 2883.15 4.93 68.76 16.72 92.18 
Std. Dev. 1.53 0.42 4.05 534.58 0.89 9.77 4.85 1.45 
Vietnam 
Mean 73.94 5.65 23.44 705.23 5.60 89.97 8.48 60.49 
Std. Dev. 1.15 0.11 4.01 209.81 0.80 6.26 2.47 9.92 
 
 
5.1 The effects of health care expenditures on life expectancy 
Table 4: Effects of health care expenditure on life expectancy at birth (LIF) 
Model Fixed Effect Random Effect 
C 
3.3306 
(142.61)*** 
3.3777 
(59.17)*** 
3.3807 
(144.15)*** 
3.4243 
(60.30)*** 
LNTHE 
0.0011 
(0.23) 
 0.0055 
(1.23) 
 
LNPUB 
 -0.0015 
(-0.45) 
 0.0001 
(0.04) 
LNPRI 
 -0.0093 
(-0.88) 
 -0.0088 
(-0.85) 
LNGDP 
0.0740 
(13.67)*** 
0.0750 
(14.21)*** 
0.0608 
(12.56)*** 
0.0631 
(13.19)*** 
LNSAN 0.0911 0.0890 0.1004 0.0972 
15 
 
(16.32)*** (15.72)*** (19.03)*** (17.97)*** 
R-squared 0.9805 0.9805 0.8888 0.8891 
Durbin-Watson 0.0857 0.0896 0.0665 0.0703 
F-Statistic 885.05 885.51 772.96 579.11 
Observations 294 294 294 294 
Cross-section included 15 15 15 15 
Notes: ***, **, and * denote significance level at 1%, 5% and 10% respectively. Figures in the parentheses are 
t-statistics. 
 
The effect of health care expenditures on life expectancy is investigated using the fixed and random effect 
models, and the results are reported in Table 4.  An increase of total health expenditures has no impact on 
life expectancy at birth (LIF) supporting the view of Filmer and Pritchett (1999) and Barlow and Vissandjee 
(1999) but contradicting with the findings of Novignon, Olakojo & Nonvignon (2012). In addition, public 
health care expenditures (PUB) and private health care expenditures (PRI) also have no impact on life 
expectancy at birth. This could be possible as life expectancy might be affected by other factors such as 
diet, life-style and environment that are not directly related to the health care system (Nixon and Ulmann 
2006). Per capita income (GDP) and sanitation (SAT) improve life expectancy at birth. The corrected 
random effect Hausman specification test confirms that fixed effect estimate is more appropriate (Chi-Sq. 
Statistic is 31.87) in this estimate. The fixed effect model is significant with an R-square of 98%, and F-
statistic 885. 
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5.2 The effects of health care expenditures on death rate 
Table 5: Effects of health care expenditures on death rate (DEA) 
Model Fixed Effect Random Effect 
C 
3.4010 
(35.49)*** 
3.8843 
(16.78)*** 
3.4273 
(35.77)*** 
3.9320 
(17.01)*** 
LNTHE 
0.0910 
(4.82)*** 
 0.0861 
(4.66)*** 
 
LNPUB 
 0.0645 
(4.69)*** 
 0.0632 
(4.65)*** 
LNPRI 
 -0.1065 
(-2.51)** 
 -0.1100 
(-2.60)*** 
LNGDP 
0.0016 
(0.07) 
0.0111 
(0.52) 
-0.0063 
(-0.32) 
0.0017 
(0.09) 
LNSAN 
-0.4173 
(-18.20)*** 
-0.4385 
(-19.11)*** 
-0.4098 
(-18.96)*** 
-0.4307 
(-19.56)*** 
R-squared 0.9637 0.9647 0.7866 0.7946 
Durbin-Watson 0.2637 0.2952 0.2403 0.2762 
F-Statistics 430.76 417.07 356.22 279.50 
Observations 294 294 294 294 
Cross-section included 15 15 15 15 
Notes: ***, **, and * denote significance level at 1%, 5% and 10% respectively. Figures in the parentheses are 
t-statistics. 
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Table 5 reveals that total health expenditure (THE) has a positive impact on death rate and show that 
increase in THE is more likely to increase infant mortality rate with 1% level of significance.   When we 
split the total health expenditures into public and private, public health expenditure (PUB) increases death 
rate, whereas, private health care expenditure (PRI) reduces death rate. While public health care expenditure 
increases the death rate by about 0.06 in both fixed and random effects models, private health care 
expenditure reduces death rate by 0.11 per 1000 people in fixed and random effect models at 1%  
significance level, respectively, supporting partially the findings of Novignon, et al (2012) from sub-
Saharan Africa. However, the studies of Berger and Messer (2002) and Hitiris and Possnett (1992) on 
OECD countries revealed that health expenditure reduced mortality rate in developed countries.  The reason 
for unexpected sign of public health care expenditure in our study may be that good governance for utilising 
public health expenditure in these countries is not maintained. If resources in public sector are inefficiently 
used, and corruption prevails, likely outcome on health status will not be achieved (Hilaire, 2016).  
Furthermore, the public health care expenditure compared to the private health care expenditure in 
developing countries like ours are manifold; since the sign of public health expenditure is positive, the 
effect of total health expenditure is also found positive (see Akinci et al 2014 for example). Additionally, 
while per capita GDP has no effect on death rate (DEA), improved sanitation facilities reduce the death 
rate. The corrected random effects of Hausman specification test confirm that random effect estimate is 
more appropriate (Chi-Sq. Statistic is 5.45) in this case. The random effect model is significant with an R-
square of 79%, and F-statistic 356. 
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5.3 The effect of health care expenditure on infant mortality rate 
Table 6: Effects of health care expenditure on infant mortality rate (MOR) 
Model Fixed Effect Random Effect 
C 
10.1249 
(52.39)*** 
11.3396 
(22.58)*** 
10.0440 
(47.78)*** 
11.2206 
(22.15)*** 
LNTHE 
-0.2683 
(-7.05)*** 
 -0.2749 
(-7.32)*** 
 
LNPUB 
 -0.0833 
(-2.79)*** 
 -0.0888 
(-3.00)*** 
LNPRI 
 -0.2383 
(-2.59)*** 
 -0.2405 
(-2.62)*** 
LNGDP 
-0.7840 
(-17.51)*** 
-0.8579 
(-18.48)*** 
-0.7581 
(-18.12)*** 
-0.8209 
(-18.89)*** 
LNSAN 
-0.2124 
(-4.59)*** 
-0.1709 
(-3.43)*** 
-0.2332 
(-5.23)*** 
-0.1996 
(-4.14)*** 
R-squared 0.9893 0.9879 0.8467 0.8267 
Durbin-Watson 0.2062 0.1751 0.1976 0.1644 
F-Statistics 1495.82 1247.25 533.76 344.70 
Observations 294 294 294 294 
Cross-section included 15 15 15 15 
Notes: ***, **, and * denote significance level at 1%, 5% and 10% respectively. Figures in the parentheses are 
t-statistics. 
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Total health care expenditures are more likely to reduce the infant mortality rate and show that a 1% 
increase in total health care expenditure (as% of GDP) leads to reduce the infant mortality rate by around 
0.27 per 1000 live births in the fixed and random effect models at 1% of significance level (Table 6). When 
we split the total healthcare expenditures into public and private, both expenditures decrease the infant 
mortality rate as expected. Both real per capita GDP and sanitation facilities reduce the infant mortality rate 
as well. These results are along the line of findings of Crémieux  et al (2005), Elola and Vicente (1995), 
Novignon, et al (2012), Issa and Ouattara (2012), Paxson and Scady (2005) and many others. The extent of 
effect of private health expenditure (0.24) is higher than that of public health expenditure (0.09) on the 
infant mortality rate. The corrected random effect Hausman specification test confirms that random effect 
estimate is more appropriate (Chi-Sq. Statistic is 3.07) in this case. The random effect model is significant 
with an R-square of 85%, and F-statistic 534. 
 
5.4 Addressing the potential endogeneity issue 
We have estimated the panel GMM results to address the potential endogeneity problem. The obtained 
results are noted in Table 7 below. We find similar results of the fixed and random effect models reported 
in Table 4 – 6 above. 
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Table 7: The results of panel Generalized Method of Moments (GMM) 
 
Dependent variable LIF DEA MOR 
C 3.3306 
(149.24)*** 
3.3777 
(84.62)*** 
3.4273 
(35.88)*** 
3.8843 
(19.85)*** 
10.1249 
(68.28)*** 
11.3396 
(25.50)*** 
LNTHE 0.0011 
(0.27) 
 0.0861 
(4.32)*** 
 -0.2683 
(-6.69)*** 
 
LNPUB  -0.0015 
(-0.43) 
 0.0645 
(3.86)*** 
 -0.0833 
(-2.88)*** 
LNPRI  -0.0093 
(-1.45) 
 -0.1065 
(-3.66)*** 
 -0.2383 
(-2.85)*** 
LNGDP 0.0740 
(13.54)*** 
0.0750 
(14.41)*** 
-0.0063 
(-0.31) 
0.0111 
(0.51) 
-0.7840 
(-19.65)*** 
-0.8579 
(-19.35)*** 
LNSAN 0.0911 
(23.36)*** 
0.0890 
22.05 
-0.4098 
(-27.80)*** 
-0.4385 
(-27.61)*** 
-0.2124 
(-4.86)*** 
-0.1709 
(-4.11)*** 
R-squared 0.9804 0.9805 0.7866 0.9646 0.9893 0.9879 
Durbin-Watson 0.0857 0.0896 0.2403 0.2952 0.2062 0.1751 
Observations 294 294 294 294 294 294 
Cross-section included 15 15 15 15 15 15 
Notes: ***, **, and * denote significance level at 1%, 5% and 10% respectively. Figures in the parentheses are 
t-statistics. 
 
Overall, our main results indicate that total health care expenditures significantly reduce the number of 
infant mortality per 1000 live births. The separate effects of public and private health expenditure on infant 
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mortality rate is also negative in the sample of selected countries. While health care expenditures have no 
effect on the life expectancy at birth, the private health expenditure has negative effect on the death rate in 
the selected sample countries. Here public and private health care expenditures provide conflicting effects 
on the death rate.  
5. Conclusion and policy implications 
 
This study has explored the role of healthcare expenditures on three important health status outcomes 
namely life expectancy at birth, crude death rate and infant mortality rate in the SAARC-ASEAN region. 
A panel data set of 15 countries for 20 years (1995-2014) is used. The separate effects of private and public 
healthcare expenditures on health outcomes are also examined. Furthermore, two controlled variables, GDP 
per capita and improved sanitation facilities, are also added in the selected models as explanatory variables. 
Our findings reveal that total health expenditures have significant effect in reducing infant mortality rate in 
the region. The separate effects of private and public health expenditures on this health status indicator are 
also negative as expected and statistically significant implying that both types of healthcare expenditures 
are essential for improving the population health. However, unlike some earlier studies, Novignon et al 
(2012) for example, the extent of effect of private health expenditure is higher than that of public health 
expenditure. This may be due to the fact that the use of public health fund in these countries is, in general, 
inefficient, and corruption is dominant. 
The private healthcare expenditure also significantly decreases the crude death rate in the region though the 
public health expenditure is showing opposite sign. Again lack of proper utilisation of public sector fund 
may be the reason. The study has not found any significant effect of healthcare expenditures on the life 
expectancy. This may be due to the reason that life expectancy depends on some other important factors 
such as life style, environment, individual education level, etc. for which we have no available data. 
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Furthermore, the per capita income growth rate has significant positive effects in increasing the life 
expectancy and reducing the infant mortality rate in the region. Improved sanitation facilities have also 
played significant positive role in increasing the life expectancy and decreasing the crude death rate and 
the infant mortality rate. 
Based on the findings the following policy implications may be drawn: (i) increased share of health 
expenditures is to be supported for increasing the health status of the population in the region. This share 
is to be more or less close to that of the developed countries; (ii) proper care must be taken for appropriate 
and efficient use of public sector health funds, and accountability and transparency must be ensured in this 
regard; (iii) efforts are to be made and adequate policies must be adopted and executed for raising the 
income level of the people to enable them to spend more on health; and (iv) further improved sanitation 
facilities are to be supported by the government and private initiatives. 
The current study faces some limitations, mainly with the data for many countries, many variables and for 
longer period. For example, we had to reduce the data set from 55 years to 20 years and from 17 countries 
to 15 countries. Also we had no data on some important variables like people’s diet, life-style, education 
level and environment which could have incorporated as explanatory variables in the models. Future 
research should address these limitations though they no way invalidate the findings of this current study. 
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